Analysis of data retrieved from human protein atlas showed that liver and pancreatic cancer patients with high PRMT3 expression levels presented with worse overall survival times compared with patients with low expression level (Supplementary Fig. 1b). The gene discussed is PRMT3; the disease is familial pancreatic carcinoma.